Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5-Reference-Cited by-同舟云学术

Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5

Published:2016-06-21 Issue:1 Volume:4 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Eng Jason W.-L.,Mace Thomas A.,Sharma Rohit,Twum Danielle Y. F.,Peng Peng,Gibbs John F.,Pitoniak Rosemarie,Reed Chelsey B.,Abrams Scott I.,Repasky Elizabeth A.,Hylander Bonnie L.

Funder

National Institutes of Health

NY Dept of Health, NYSTEM

Roswell Park Alliance Foundation, Roswell Park Cancer Institute

American Medical Association Foundation

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0136-y

Reference39 articles.

1. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21. doi: 10.1158/0008-5472.can-14-0155 .

2. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960–6. doi: 10.1200/jco.2006.07.9525 .

3. Sullivan KM, Kozuch PS. Chemotherapy and other supportive modalities in the palliative setting for pancreatic cancer. Cancer J (Sudbury, Mass). 2012;18(6):633–41. doi: 10.1097/PPO.0b013e318275896f .

4. Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–703. doi: 10.1056/NEJMoa1304369 .

5. Simeone DM. Pancreatic cancer stem cells: implications for the treatment of pancreatic cancer. Clin Cancer Res. 2008;14(18):5646–8. doi: 10.1158/1078-0432.CCR-08-0584 .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and future prospective of caspases targeting in cancer therapy;Caspases as Molecular Targets for Cancer Therapy;2024

2. EZH2 regulates pancreatic cancer cells through E2F1, GLI1, CDK3, and Mcm4;Hereditas;2023-05-17

3. microRNA-21-5p from M2 macrophage-derived extracellular vesicles promotes the differentiation and activity of pancreatic cancer stem cells by mediating KLF3;Cell Biology and Toxicology;2021-03-17

4. Clinical trials of promising apoptosis modulating drugs;Clinical Perspectives and Targeted Therapies in Apoptosis;2021

5. An Application of CHNN for FANETs Routing Optimization;Journal of Web Engineering;2020-12-14